Amrixa Pharmaceuticals is an novel biotherapeutics company seeking to develop and commercialize first-in-class mRNA-based medicines. We are currently engaged in preclinical R&D to de-risk our lead asset.
Amrixa is a resident startup of BioLabs LA @ The Lundquist Institute and member corporation of Biocom, California Life Sciences, and SoCalBio.
We are preparing to raise funds for our IND-enabling package, and we can be reached by email at info@amrixapharmaceuticals.com.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 1124 West Carson Street, Medical Research Laboratory
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- West Sacramento.
- HQ
- Torrance, CA
Amrixa Pharmaceuticals Questions
Amrixa Pharmaceuticals's website is https://www.amrixapharmaceuticals.com
Amrixa Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/amrixa
Amrixa Pharmaceuticals has
1 employees.
View email and phone details for 1
employees at Amrixa Pharmaceuticals.
Amrixa Pharmaceuticals's industry is
Biotechnology Research
Amrixa Pharmaceuticals's top competitors are
Volochem,
West Coast Biotechnology,
The Eli And Edythe Broad Foundation,
Biomark Oncology,
Branchpoint Biosciences,
Eppendorf,
Mesh Strategic Partnerships, Keck School Of Medicine Of Usc,
Magnify Incubator,
The Science Learning Foundation,
Nucleate Los Angeles.
Amrixa Pharmaceuticals's categories are Biotechnology Research
Amrixa Pharmaceuticals's founding year is 2024
